Axon Enterprise Stock Forecast, Price & News

Axon Enterprise (NASDAQ:AXON) Frequently Asked Questions

Is Axon Enterprise a buy right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Axon Enterprise in the last year. There are currently 1 hold rating, 6 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Axon Enterprise stock.
View analyst ratings for Axon Enterprise or view top-rated stocks.

When is Axon Enterprise's next earnings date?

Axon Enterprise is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for Axon Enterprise.

How were Axon Enterprise's earnings last quarter?

Axon Enterprise, Inc. (NASDAQ:AXON) announced its quarterly earnings results on Monday, November, 15th. The biotechnology company reported $1.17 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.26 by $0.91. The biotechnology company earned $231.99 million during the quarter, compared to analysts' expectations of $201.11 million. Axon Enterprise had a negative trailing twelve-month return on equity of 2.26% and a negative net margin of 2.37%. Axon Enterprise's revenue was up 39.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.01) earnings per share.
View Axon Enterprise's earnings history.

What guidance has Axon Enterprise issued on next quarter's earnings?

Axon Enterprise updated its FY 2021 earnings guidance on Monday, December, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $850 million-$850 million, compared to the consensus revenue estimate of $843.58 million.

What price target have analysts set for AXON?

8 analysts have issued 1 year price targets for Axon Enterprise's shares. Their forecasts range from $170.00 to $250.00. On average, they expect Axon Enterprise's stock price to reach $208.43 in the next year. This suggests a possible upside of 35.5% from the stock's current price.
View analysts' price targets for Axon Enterprise or view top-rated stocks among Wall Street analysts.

Who are Axon Enterprise's key executives?

Axon Enterprise's management team includes the following people:

• Patrick W. Smith, Chief Executive Officer & Director (LinkedIn Profile)
• Luke S. Larson, President (LinkedIn Profile)
• Josh Goldman, Senior Vice President-Operations
• Jawad A. Ahsan, Chief Financial Officer (LinkedIn Profile)
• Jenner Holden, Chief Information Security Officer

Who are some of Axon Enterprise's key competitors?

Some companies that are related to Axon Enterprise include Microsoft (MSFT), Oracle (ORCL), ServiceNow (NOW), Fortinet (FTNT), VMware (VMW), Qualys (QLYS), C3.ai (AI), Commvault Systems (CVLT), Progress Software (PRGS) and FalconStor Software (FALC).
View all of AXON's competitors.

What other stocks do shareholders of Axon Enterprise own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axon Enterprise investors own include Novavax (NVAX), NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), (CGC), Micron Technology (MU), TherapeuticsMD (TXMD), ACADIA Pharmaceuticals (ACAD), bluebird bio (BLUE) and Arena Pharmaceuticals (ARNA).

When did Axon Enterprise IPO?

(AXON) raised $251 million in an initial public offering on Thursday, June 11th 2015. The company issued 17,900,000 shares at a price of $13.00-$15.00 per share. Jefferies, Evercore ISI and RBC Capital Markets served as the underwriters for the IPO and JMP Securities and Baird were co-managers.

What is Axon Enterprise's stock symbol?

Axon Enterprise trades on the NASDAQ under the ticker symbol "AXON."

Who are Axon Enterprise's major shareholders?

Axon Enterprise's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (10.57%), Baillie Gifford & Co. (6.91%), William Blair Investment Management LLC (2.86%), Morgan Stanley (2.70%), Lord Abbett & CO. LLC (2.11%) and Alliancebernstein L.P. (2.02%). Company insiders that own Axon Enterprise stock include Caitlin Elizabeth Kalinowski, Jawad A Ahsan, Jeffrey C Kunins, Joshua Isner, Julie A Cullivan, Luke Larson, Matthew R Mcbrady, Matthew R Mcbrady and Patrick W Smith.
View institutional ownership trends for Axon Enterprise.

Which institutional investors are selling Axon Enterprise stock?

AXON stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Janus Henderson Group PLC, TimesSquare Capital Management LLC, Invesco Ltd., NorthCoast Asset Management LLC, Morgan Stanley, William Blair Investment Management LLC, and UBS Group AG. Company insiders that have sold Axon Enterprise company stock in the last year include Jawad A Ahsan, Jeffrey C Kunins, Joshua Isner, Julie A Cullivan, Luke Larson, Matthew R Mcbrady, and Patrick W Smith.
View insider buying and selling activity for Axon Enterprise or view top insider-selling stocks.

Which institutional investors are buying Axon Enterprise stock?

AXON stock was purchased by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Conestoga Capital Advisors LLC, Wellington Management Group LLP, Retirement Systems of Alabama, Franklin Resources Inc., Defender Capital LLC., New York State Teachers Retirement System, and Allianz Asset Management GmbH.
View insider buying and selling activity for Axon Enterprise or or view top insider-buying stocks.

How do I buy shares of Axon Enterprise?

Shares of AXON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Axon Enterprise's stock price today?

One share of AXON stock can currently be purchased for approximately $153.79.

How much money does Axon Enterprise make?

Axon Enterprise has a market capitalization of $10.53 billion and generates $681 million in revenue each year. The biotechnology company earns $-1.72 million in net income (profit) each year or ($0.40) on an earnings per share basis.

How many employees does Axon Enterprise have?

Axon Enterprise employs 2,548 workers across the globe.

What is Axon Enterprise's official website?

The official website for Axon Enterprise is www.axovant.com.

Where are Axon Enterprise's headquarters?

Axon Enterprise is headquartered at 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS.

How can I contact Axon Enterprise?

Axon Enterprise's mailing address is 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS. The biotechnology company can be reached via phone at (480) 991-0797, via email at [email protected], or via fax at 480-991-0791.